Navigation Links
Treatment of Sickle Cell Anemia Using Gene Therapy.

A research was conducted by Selda Samakoglu and colleagues at the Memorial Sloan-Kettering Cancer Center. This research opened new doors in the treatment of the genetic disease, Sickle cell anemia // . The treatment combines both gene therapy and RNA interference therapy. So far the treatment has worked well in the laboratory stage and will be of great success in curing the disorder.

Sickle cell disease is a genetic disease affecting 80,000 people in the US alone. The Red Blood Cells (RBCs) become lose there normal disk shape and become sickle shaped. Due to this abnormality there is hindrance in the movement of these sickled RBC. The movement inside the small blood vessels is restricted and this results in piling, clumping inside the vessels. This eventually blocks the vessels leading to stroke, pain, infection and organ damage.

This disease is very much prevalent among the Africans, Mediterranean, Indian or Middle Eastern individuals. At present the treatment is that the affected people are given a stem cell transplant from a donor. It is very difficult to find an exact mach and less than 20% of the children suffering from the diseases find a complete donor match.

The researchers said that at the moment they are working with animal model (mice) and after the tests results prove to be positive they will start human trails and bring about the treatment procedure in the main stream of medicine within a few years.

The stem cells taken from the bone marrow are cultured in the lab and a small RNA sequence that interferes with the production of beta S-globin is integrated. This is because this sequence that produces beta S-globin is altered in these patients hence the altered gene is prevented from getting translated to proteins. This set up is then inserted in a gene that promotes production of healthy hemoglobin chains.

The net result is the production of a transgene which is then inserted into a vector (virus) and i
'"/>




Page: 1 2

Related medicine news :

1. Advances in Treatment of Cataracts
2. Recommendations for Treatment of Blood Pressue
3. Treatment for Menieres disease
4. Treatment for pre-menstrual syndrome is ineffective
5. Better Treatment for obesity
6. Gene Treatment for Heart Disease
7. More People Seeking Treatment for Depression
8. Focused Treatment For Childhood Cancer
9. Inadequate Drug Treatment For Youth
10. FDA Approves New surgery Treatment for Farsightedness
11. Treatment of antibiotics ineffectual in bronchitis

Post Your Comments:
(Date:12/3/2009)...RNewswire/ -- Chiltern International Limited (Chil...O) providing clinical development and staffing ser...unces the appointment of Dr. Sharon Moore as Exe...l Affairs. Dr. Moore is based at Chiltern,s Bristo...sician with 15 years of industry experience. Prior...
(Date:12/3/2009)...c. 3 If you have seen "Super Size ...unning look at the other side of the dining table....er feature documentary, "Supercharge Me! 30 Days R..., 5 p.m. at Sever Hall, Harvard Yard. The event is...our. The film will be followed by a lecture and di...
(Date:12/3/2009)... wing shapes changed rapidly, researchers say , ...y people think evolution takes hundreds, if not th...nd new research shows exactly how: The simple act ... effect on a population of birds. , Researcher...edition of Current Biology , said a single popula...
(Date:12/3/2009)...Newswire-USNewswire/ -- The following is being rel....S. Senate Judiciary Committee Chairman Patrick Le... care reform bill that would repeal the health ins...such as price fixing, bid rigging and market alloc... repeal, which would subject health insurance comp...
(Date:12/3/2009)...w cases created by a single case of H1N1 influenza...ination, social distancing and the use of antivira... virus, suggests an epidemiological modelling stud... reported in CMAJ ( Canadian Medical Associatio...t data from laboratory-confirmed cases of H1N1 bet...
Breaking Medicine News(10 mins):Health News:Chiltern Names Dr. Sharon Moore as Executive VP, Global Quality & Medical Affairs 2Health News:Jenna Norwood to Present Award-Winning Documentary & Lecture at Harvard University 2Health News:Feeding Birds in Winter Could Speed Evolution of Species 2Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 2Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 3Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 4Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 5Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 6Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 7Health News:Health Insurance Industry Once Again Hoping Investment Pays Off 8Health News:Vaccination, antivirals and social distancing may blunt impact of H1N1 influenza 2
...ogies (OTC Bulletin Board: PSTX) today announced r...tember 30, 2008. , "We are pleased to see th...e institutions across the U.S. translate into incr...ncidents of retained,sponges, current and potentia...
...ses and 79,working Chambers of Commerce throughout...oyees and members an extensive portfolio of life a...veloped by Anthem Life Insurance Company,(Anthem L...up,with the Chamber Insurance Trust in our launch ...
... DoseTrac(TM) Improves Communication and Safety, P...24 In an industry first that will help healthcare...ation errors as they streamline care, B. Braun Med...face capabilities . , , (LOGO: http://www.n...
..., a wholly owned subsidiary of Mercury Computer Sy...gned a comprehensive marketing agreement,with Viat...al imaging and,diagnostic software. Under the agre...s Viatronix,s domestic marketing arm, while,extend...
...uticals,Inc., a privately-held specialty pharmaceu...sen, President & Chief Executive Officer, is s...ay Health Care Conference in New York,City on Tues...ces . The replay of the presentation will,be avail...
... premier,transplant reference and consultative lab...oska, a leading figure in the field of immunology,... of Laboratory Directors. , Dr. Pancoska has...LA Laboratory, Community Blood Center of Paramus N...
Other Medicine News:Health News:Patient Safety Technologies Reports Third Quarter 2008 Results 2Health News:Patient Safety Technologies Reports Third Quarter 2008 Results 3Health News:Patient Safety Technologies Reports Third Quarter 2008 Results 4Health News:Patient Safety Technologies Reports Third Quarter 2008 Results 5Health News:Patient Safety Technologies Reports Third Quarter 2008 Results 6Health News:Anthem Blue Cross and Blue Shield and Anthem Life in Connecticut Partner with the Chamber Insurance Trust to Offer Life and Disability Products to Chamber of Commerce Members 2Health News:Anthem Blue Cross and Blue Shield and Anthem Life in Connecticut Partner with the Chamber Insurance Trust to Offer Life and Disability Products to Chamber of Commerce Members 3Health News:B. Braun's DoseTrac(TM) Software: Making Connections to Better Manage IV Therapy 2Health News:B. Braun's DoseTrac(TM) Software: Making Connections to Better Manage IV Therapy 3Health News:B. Braun's DoseTrac(TM) Software: Making Connections to Better Manage IV Therapy 4Health News:Visage Imaging and Viatronix Sign Comprehensive Marketing Agreement for Virtual Colonoscopy Product 2Health News:Visage Imaging and Viatronix Sign Comprehensive Marketing Agreement for Virtual Colonoscopy Product 3Health News:Visage Imaging and Viatronix Sign Comprehensive Marketing Agreement for Virtual Colonoscopy Product 4Health News:Transcept Pharmaceuticals, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference 2Health News:LABS Inc. Adds Dr. Carol Pancoska as Laboratory Director 2
(Date:12/3/2009)..., Dec. 3 VirtualScopics,...ntitative imaging for clinical trials, announced t... 4D Reconstruction and Visualization" recently rec...e President of Technology and Product Development,...apan has recognized the uniqueness of VirtualScopi...
(Date:12/3/2009)...NG, China, Dec. 3 /PRNewswire-Asia/ -- Simcere Pha...SE: SCR ), a leading pharmaceutical company,spec...rketing of branded,generic and proprietary pharmac...te Food and Drug Administration ("SFDA") has initi...sues regarding human use rabies vaccine (vero,cell...
(Date:12/3/2009)... and NEEDHAM, Massachusetts, December 3 /PRNewswir...change: ORIDN) today announced that the Bavarian R...hs for its RTW (Rettungswagen) medical vehicles. T...assess the ventilation status of a patient as well...tatus such as displaced endotracheal tubes, episod...
Breaking Medicine Technology:VirtualScopics Receives Issuance in Japan of Prominent Patent 2VirtualScopics Receives Issuance in Japan of Prominent Patent 3Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 2Simcere Pharmaceutical Group Provides Update on Jiangsu Yanshen 3Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 2Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 3Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 4BioCryst to Present at Oppenheimer Healthcare Conference 5852 1BioCryst to Present at Oppenheimer Healthcare Conference 5852 2New Data Show Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using 5850 1New Data Show Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using 5850 2New Data Show Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using 5850 3New Data Show Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using 5850 4New Data Show Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using 5850 5New Data Show Once Daily INTUNIV 28TM 29 28guanfacine 29 Extended Release Tablets Demonstrated Significant ADHD Symptom Reduction when Assessed Using 5850 6Laying Still Raises Artificial Insemination Success 60356 1Laying Still Raises Artificial Insemination Success 60356 2Laying Still Raises Artificial Insemination Success 60356 3
...se III Studies With Ofatumumab, Zalutumumab and Za...S (OMX:,GEN) reports today that the last patient t...32 patients) in the pivotal Phase III clinical tri...onic lymphocytic leukemia,(CLL) has now received t...e the database and allow for assessment of the,res...
...y 28 Robert Brackett, chief,science officer for t...released the following statement in response to th...orted in the latest issue of the Journal of the,Am...he findings reported in today,s issue of the Journ...cating that the rise in,childhood and teen obesity...
Other Medicine Technology:Genmab Announces Updates on Phase III Cancer Studies 2Genmab Announces Updates on Phase III Cancer Studies 3
...stem combines the longest available wavelength wit...afety and efficacy. The unique flat beam profile c...ge to all targeted structures. The Lyra-I uniquely...All Lyra-I patients are protected by patented cont...
... Aura-i Laser System is a compact, highly portable...d procedures. Its unique, integrated StarPulse fea...r, including telangiectasia on the leg and face, a... It can also be used as a continuous wave laser fo...
Surgisis® IHM™ Inguinal Hernia Matrix
Surgisis® GOLD™ Hernia Repair Grafts
Medicine Products: